CT、MR、SPECT在“脑先行型”肺癌脑转移诊断治疗中的价值  

Value of CT、MRI and SPECT in Diagnosis and Treatment for “Cerebral Preceding” Metastatic Cancers from Lungs

作　　者：谭平国[1] 钟伟健[1] 蔡望青[1] 钟志光[1] 

机构地区：[1]中山医科大学孙逸仙纪念医院神经外科

出　　处：《实用癌症杂志》1999年第1期38-40,共3页The Practical Journal of Cancer

摘　　要：为了评估ＣＴ、ＭＲ与ＳＥＰＣＴ在“脑先行型”肺癌脑转移诊断治疗中的价值，回顾性分析了１９９２年５月至１９９７年５月收治的３０例“脑先行型”肺癌脑转移瘤的ＣＴ、ＭＲ脑扫描与ＳＰＥＣＴ全身骨扫描的临床资料。结果表明，ＣＴ检查对本病的早期发现及诊断有重要价值；而ＭＲ在确定脑转移瘤是否多发则更是必不可少的；ＳＰＥＣＴ在确定骨转移有很大的参考作用。可以认为这３种先进的诊断手段如果合理运用，对“脑先行型”To assess the value of CT,MRI and SPECT in diagnosis of “Cerebral Preceding” metastatic cancers from lungs,30 cases of “Cerebral Preceding” metastatic cancers from lungs in our hospital from May 1992 to May 1997 were analyzed.CT provided early diagnosis of the disease,MR was necessary to confirmed multi metastasis and SPECT helped to rule out metastatic cancers of bones.Combination of the 3 methods could be helpful for diagnosis and to make treating protocol for “Cerebral Preceding” metastatic cancers from lungs.

关 键 词：脑转移瘤 肺癌 CT 核磁共振 SPECT 诊断 

分 类 号：R734.2[医药卫生—肿瘤] R739.410.4[医药卫生—临床医学]